Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Submitted by
admin
on December 7, 2015 - 3:08pm
Source:
Yahoo/Reuters
News Tags:
Novartis
CAR-T
CTL019
non-Hodgkins lymphoma
Headline:
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Do Not Allow Advertisers to Use My Personal information
